# Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion

> **NCT00797550** · PHASE1,PHASE2 · TERMINATED · sponsor: **Vericel Corporation** · enrollment: 2 (actual)

## Conditions studied

- Single Level Posterolateral Spinal Fusion

## Interventions

- **BIOLOGICAL:** Bone Repair Cells (BRCs)
- **PROCEDURE:** Autologous bone graft

## Key facts

- **NCT ID:** NCT00797550
- **Lead sponsor:** Vericel Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2006-08
- **Final completion:** 2008-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was terminated early for business reasons (not safety reasons).
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797550, "Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00797550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*